Identification of secreted phosphoprotein 1 gene as a new rheumatoid arthritis susceptibility gene

Annals of the Rheumatic Diseases

Volumn 74, Issue 3, 2015, Pages

  Gazal, Steven ^a   Sacre, Karim ^b   Allanore, Yannick ^b,c   Teruel, Maria ^d   Goodall, Alison H ^e   Tohma, Shigeto ^f   Alfredsson, Lars ^g   Okada, Yukinori ^h,i,j   Xie, Gang ^k   Constantin, Arnaud ^l   Balsa, Alejandro ^m   Kawasaki, Aya ^f   Nicaise, Pascale ^b   Amos, Christopher ⁿ   Rodriguez Rodriguez, Luis ^o   Chiocchia, Gilles ^c   Boileau, Catherine ^p   Zhang, Jinyi ^k   Vittecoq, Olivier ^q   Barnetche, Thomas ^r   Gonzalez Gay, Miguel A ^s   Furukawa, Hiroshi ^f   Cantagrel, Alain ^l   Le Loët, Xavier ^q   Sumida, Takayuki ^t   Hurtado Nedelec, Margarita ^b,u   Richez, Christophe ^r   Chollet Martin, Sylvie ^b   Schaeverbeke, Thierry ^r   Combe, Bernard ^v   Khoryati, Liliane ^r   Coustet, Baptiste ^a   El Benna, Jammel ^u   Siminovitch, Katherine ^k   Plenge, Robert ^w   Padyukov, Leonid ^g   Martin, Javier ^d   Tsuchiya, Naoyuki ^f   Dieudé, Philippe ^a,p   more..

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT COCHIN   (France)

^d INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f UNIVERSITY OF TSUKUBA   (Japan)

^g KAROLINSKA INSTITUTE   (Sweden)

^h TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

ⁱ Institute of Physical and Chemical Research   (Japan)

^j BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^k UNIVERSITY OF TORONTO   (Canada)

^l UNIVERSITÉ PAUL SABATIER   (France)

^m HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

ⁿ DARTMOUTH MEDICAL SCHOOL   (United States)

^o HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^p INSERM   (France)

^q UNIVERSITY OF ROUEN   (France)

^r HÔPITAL PELLEGRIN   (France)

^s HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^t NATIONAL HOSPITAL ORGANIZATION   (Japan)

^u CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^v MONTPELLIER UNIVERSITY HOSPITAL   (France)

^w MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; OSTEOPONTIN; AUTOANTIBODY; CITRULLINE; PEPTIDE; SPP1 PROTEIN, HUMAN;

ANTIBODY PRODUCTION; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE TRAIT LOCUS; RHEUMATOID ARTHRITIS; SPP1 GENE; ALLELE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; IMMUNOLOGY; METABOLISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; CASE-CONTROL STUDIES; CITRULLINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MACROPHAGES; MALE; OSTEOPONTIN; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 85027946337     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204581     Document Type: Article

References (56)

1. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet 2010; 376: 1094-108.
2. Stahl EA, Raychaudhuri S, Remmers EF, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010; 42: 508-14.
3. Zhernakova A, Stahl EA, Trynka G, et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet 2011; 7: e1002004.
4. Eyre S, Bowes J, Diogo D, et al. High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. Nat Genet 2012; 44: 1336-40.
5. Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis-a genomewide study. N Engl J Med 2007; 357: 1199-209.
6. Raychaudhuri S, Remmers EF, Lee AT, et al. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet 2008; 40: 1216-23.
7. Remmers EF, Plenge RM, Lee AT, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357: 977-86.
8. Plenge RM, Cotsapas C, Davies L, et al. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet 2007; 39: 1477-82.
9. Wellcome Trust Case Control C. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007; 447: 661-78.
10. van der Woude D, Houwing-Duistermaat JJ, Toes RE, et al. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis Rheum 2009; 60: 916-23.
11. Kurreeman F, Liao K, Chibnik L, et al. Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records. Am J Hum Genet 2011; 88: 57-69.
12. Padyukov L, Seielstad M, Ong RT, et al. A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis. Ann Rheum Dis 2011; 70: 259-65.
13. van der Pouw Kraan TC, van Baarsen LG, Wijbrandts CA, et al. Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patients. Genes Immun 2008; 9: 16-22.
14. van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, et al. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Ann Rheum Dis 2007; 66: 1008-14.
15. Briggs TA, Rice GI, Daly S, et al. Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 2011; 43: 127-31.
16. Lausch E, Janecke A, Bros M, et al. Genetic deficiency of tartrate-resistant acid phosphatase associated with skeletal dysplasia, cerebral calcifications and autoimmunity. Nat Genet 2011; 43: 132-7.
17. Denhardt DT, Noda M. Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl 1998; 30-31: 92-102.
18. Lampe MA, Patarca R, Iregui MV, et al. Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. J Immunol 1991; 147: 2902-6.
19. Shinohara ML, Lu L, Bu J, et al. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 2006; 7: 498-506.
20. Ohshima S, Yamaguchi N, Nishioka K, et al. Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol 2002; 29: 2061-7.
21. Ohshima S, Kobayashi H, Yamaguchi N, et al. Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis. Arthritis Rheum 2002; 46: 1094-101.
22. Barizzone N, Marchini M, Cappiello F, et al. Association of osteopontin regulatory polymorphisms with systemic sclerosis. Hum Immunol 2011; 72: 930-4.
23. Kikuchi K, Tanaka A, Miyakawa H, et al. Eta-1/osteopontin genetic polymorphism and primary biliary cirrhosis. Hepatol Res 2003; 26: 87-90.
24. Chiocchetti A, Orilieri E, Cappellano G, et al. The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population. Int J Immunopathol Pharmacol 2010; 23: 263-9.
25. Chiocchetti A, Indelicato M, Bensi T, et al. High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/ lymphoproliferation. Blood 2004; 103: 1376-82.
26. Forton AC, Petri MA, Goldman D, et al. An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat 2002; 19: 459.
27. D'Alfonso S, Barizzone N, Giordano M, et al. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2005; 52: 539-47.
28. Han S, Guthridge JM, Harley IT, et al. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction. PLoS One 2008; 3: e0001757.
29. Kariuki SN, Moore JG, Kirou KA, et al. Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes Immun 2009; 10: 487-94.
30. Giacopelli F, Marciano R, Pistorio A, et al. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol Genomics 2004; 20: 87-96.
31. Glas J, Seiderer J, Bayrle C, et al. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease. PLoS One 2011; 6: e29309.
32. Comi C, Cappellano G, Chiocchetti A, et al. The impact of osteopontin gene variations on multiple sclerosis development and progression. Clin Dev Immunol 2012; 2012: 212893.
33. Combe B, Benessiano J, Berenbaum F, et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007; 74: 440-5.
34. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
35. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75.
36. Akaike H. Factor analysis and AIC. Psychometrica 1987; 52: 317-32.
37. Inoue M, Shinohara ML. Intracellular osteopontin (iOPN) and immunity. Immunol Res 2011; 49: 160-72.
38. Schunkert H, Konig IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011; 43: 333-8.
39. Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 2009; 5: e1000529.
40. Genomes Project C, Abecasis GR, Altshuler D, et al. A map of human genome variation from population-scale sequencing. Nature 2010; 467: 1061-73.
41. Huizinga TW, Amos CI, van der Helm-van Mil AH, et al. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis Rheum 2005; 52: 3433-8.
42. Seddighzadeh M, Gonzalez A, Ding B, et al. Variants within STAT genes reveal association with anticitrullinated protein antibody-negative rheumatoid arthritis in 2 European populations. J Rheumatol 2012; 39: 1509-16.
43. Syversen SW, Gaarder PI, Goll GL, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008; 67: 212-17.
44. Tahri-Daizadeh N, Tregouet DA, Nicaud V, et al. Automated detection of informative combined effects in genetic association studies of complex traits. Genome Res 2003; 13: 1952-60.
45. Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003; 56: 73-82.
46. Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011; 365: 1612-23.
47. Sirota M, Schaub MA, Batzoglou S, et al. Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet 2009; 5: e1000792.
48. Chiocchetti A, Comi C, Indelicato M, et al. Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. J Neuroimmunol 2005; 163: 172-8.
49. Hunt KA, Mistry V, Bockett NA, et al. Negligible impact of rare autoimmune-locus coding-region variants on missing heritability. Nature 2013; 498: 232-5.
50. O'Regan AW, Hayden JM, Berman JS. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol 2000; 68: 495-502.
51. Le Bon A, Schiavoni G, D'Agostino G, et al. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14: 461-70.
52. Bos CL, van Baarsen LG, Timmer TC, et al. Molecular subtypes of systemic sclerosis in association with anti-centromere antibodies and digital ulcers. Genes Immun 2009; 10: 210-18.
53. Bilgic H, Ytterberg SR, Amin S, et al. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis Rheum 2009; 60: 3436-46.
54. Emamian ES, Leon JM, Lessard CJ, et al. Peripheral blood gene expression profiling in Sjogren's syndrome. Genes Immun 2009; 10: 285-96.
55. van Baarsen LG, Bos WH, Rustenburg F, et al. Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis. Arthritis Rheum 2010; 62: 694-704.
56. Trivedi T, Franek BS, Green SL, et al. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol 2011; 2011: 802581.